Estudo RECOVERY | Aspirina como terapia complementar não reduziu a mortalidade em pacientes internados com COVID-19.

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – The Lancet

Comentário convidado: Studying the coagulopathy of COVID-19 – The Lancet

Comentário do autor no Twitter (fio – clique para saber mais)

RECOVERY Publication: ASPIRIN
(a widely used anti-platelet treatment in other settings)

14 892 patients hospitalised with COVID-19.

No impact on mortality.
Small improvement in hospital stay.
No impact on need for mechanical ventilation
6 more bleeds. 6 fewer thromboses (clots) pic.twitter.com/LxDzudss9F

— Martin Landray (@MartinLandray) November 18, 2021